ASND Message Board | Ascendis Pharma A/S

Short today at 85.34

DWhitStocks · 2023-05-01

ASND Message Board | Ascendis Pharma A/S Short today at 85.34

ASND ASND Quote ASND Short ASND News ASND Articles ASND Message Board

New Post

Subject	By	Source	When
Short today at 85.34	MiamiGent	investorshub	05/01/2023 8:42:43 PM
Ascendis Pharma: FDA Approves Skytrofa to Treat Pediatric	crudeoil24	investorshub	08/25/2021 9:19:58 PM
ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company,	crudeoil24	investorshub	08/25/2021 9:17:30 PM

Stock Information

Ascendis Pharma A/S Company Name:

ASND Stock Symbol:

NASDAQ Market:

Ascendis Pharma A/S Website:

ASND - Ascendis Presents TransCon(TM) PTH Data at the American Thyroid Association Annual Meeting

– At Week 26, 81% of patients in Phase 3 PaTHway Trial with chronic post-surgical hypoparathyroidism, the most common cause of this disease, achieved independence from conventional therapy while maintaining normocalcemia following treatment with TransCon PTH – Post...
ASND - Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty | Benzinga

Raymond James initiated coverage on BioMarin Pharmaceuticals Inc (NASDAQ: BMRN) with a Market Perform rating, noting sparsity in&nbs...
ASND - Ascendis Pharma Presents Results from Long-Term enliGHten Trial of TransCon(TM) hGH in Pediatric Growth Hormone Deficiency

- The majority of children and adolescents treated once weekly with TransCon hGH (lonapegsomatropin) met or exceeded average parental height SDS at time of treatment completion or last visit - Trial demonstrated the long-term safety of TransCon hGH in patients treated up to 6 years ...